Karyopharm Therapeutics (KPTI) Receivables (2019 - 2026)
Karyopharm Therapeutics' Receivables came in at $29.87 million for Q2 2026, down 9.3% from $32.93 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Receivables was $26.18 million, down 14.9% from FY2024.
- Receivables carries a five-year compound annual growth rate of 15.2% (FY2020 to FY2025).
- Going back by year, Receivables was $30.77 million in FY2024 (+14.1%), $26.96 million in FY2023 (-42.7%), $47.09 million in FY2022 (+109.3%) and $22.5 million in FY2021 (+74.4%).
- The five-year range for quarterly Receivables is $18.75 million (Q3 2021) to $47.09 million (Q4 2022).
- Year-over-year, Receivables increased in three of the last seven quarters, with an average decline of 3.7%.
- The fastest year-over-year change in Receivables over five years came in Q4 2022 (growth of 109.3%), and the weakest in Q4 2023 (a decline of 42.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Karyopharm Therapeutics | 11.50 Mn | -214.92 Mn | 32.35 Mn | 29.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.87 Mn |
| Dec 31, 2025 | 26.18 Mn |
| Sep 30, 2025 | 31.88 Mn |
| Jun 30, 2025 | 32.93 Mn |
| Mar 31, 2025 | 35.24 Mn |
| Dec 31, 2024 | 30.77 Mn |
| Sep 30, 2024 | 31.78 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Mar 31, 2024 | 31.08 Mn |
| Dec 31, 2023 | 26.96 Mn |
| Sep 30, 2023 | 37.92 Mn |
| Jun 30, 2023 | 32.28 Mn |
| Mar 31, 2023 | 35.20 Mn |
| Dec 31, 2022 | 47.09 Mn |
| Sep 30, 2022 | 27.45 Mn |
| Jun 30, 2022 | 23.48 Mn |
| Mar 31, 2022 | 24.99 Mn |
| Dec 31, 2021 | 22.50 Mn |
| Sep 30, 2021 | 18.75 Mn |
| Jun 30, 2021 | 17.89 Mn |
API Access
Karyopharm Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();